|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0001792,
umls-concept:C0003009,
umls-concept:C0009240,
umls-concept:C0030705,
umls-concept:C0033325,
umls-concept:C0038454,
umls-concept:C0199176,
umls-concept:C0205409,
umls-concept:C0221155,
umls-concept:C0332307,
umls-concept:C0717550,
umls-concept:C1710028,
umls-concept:C2603343
|
|
pubmed:issue |
6
|
|
pubmed:dateCreated |
2004-9-14
|
|
pubmed:abstractText |
The aim of this study was to test the hypothesis that the angiotensin II type 1 receptor blocker (ARB) candesartan can reduce the risk of stroke in elderly patients with isolated systolic hypertension (ISH).
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Sep
|
|
pubmed:issn |
0735-1097
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
15
|
|
pubmed:volume |
44
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1175-80
|
|
pubmed:dateRevised |
2007-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:15364316-Aged,
pubmed-meshheading:15364316-Aged, 80 and over,
pubmed-meshheading:15364316-Angiotensin II Type 1 Receptor Blockers,
pubmed-meshheading:15364316-Antihypertensive Agents,
pubmed-meshheading:15364316-Benzimidazoles,
pubmed-meshheading:15364316-Blood Pressure,
pubmed-meshheading:15364316-Double-Blind Method,
pubmed-meshheading:15364316-Europe,
pubmed-meshheading:15364316-Female,
pubmed-meshheading:15364316-Follow-Up Studies,
pubmed-meshheading:15364316-Humans,
pubmed-meshheading:15364316-Hydrochlorothiazide,
pubmed-meshheading:15364316-Hypertension,
pubmed-meshheading:15364316-Male,
pubmed-meshheading:15364316-Receptor, Angiotensin, Type 1,
pubmed-meshheading:15364316-Risk Factors,
pubmed-meshheading:15364316-Stroke,
pubmed-meshheading:15364316-Systole,
pubmed-meshheading:15364316-Tetrazoles,
pubmed-meshheading:15364316-Time Factors,
pubmed-meshheading:15364316-Treatment Outcome
|
|
pubmed:year |
2004
|
|
pubmed:articleTitle |
Stroke prevention with the angiotensin II type 1-receptor blocker candesartan in elderly patients with isolated systolic hypertension: the Study on Cognition and Prognosis in the Elderly (SCOPE).
|
|
pubmed:affiliation |
Hypertension and Cardiovascular Research, Veterans Administration Medical Center, Washington, DC 20422, USA. papavip@aol.com
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
